Blog & Media
Ideas & Updates from innoscripta
Explore stories, insights, and innovations from the people building the future of R&D and digital tax technology.
Jun 24, 2026
boersengefluester.de highlights innoscripta’s platform strategy and international growth momentum
boersengefluester.de highlights CFO Alexander Meyer’s presentation at the Deutsche Börse Scale Summit, emphasising innoscripta’s international expansion and the growth opportunities enabled by its platform. The article focuses on the company’s technological positioning in R&D process management, its first customer wins in France, as well as its growth strategy and strong operational performance.Read more: https://publisher.boersengefluester.de/de/innoscripta-uberzeugende-vorstellung
Jun 16, 2026
Need for external advice when applying for Research Allowance
Any company conducting research and development (R&D) projects in Germany can apply for state financial support under the Research Allowance Act (Forschungszulagengesetz). The research allowance is granted to companies with eligible research projects in the form of a tax credit; this is offset against their income tax liability and thereby significantly reducing the tax burden. Companies with no tax liability, or whose tax liability is lower than the amount of the granted allowance, receive this financial support as a direct cash payment.The application process for the research allowance consists of two steps and requires a clear, meticulously prepared application. This must include a precise project description, costs that are eligible under the Frascati criteria, and appropriate supporting documentation to substantiate the claims. Companies often struggle to prepare a successful application due to the process's complexity and ambiguities; consequently, applications for the research allowance are sometimes rejected, even when the underlying R&D work is excellent.Given these challenges, companies require expert support and a holistic "one-stop solution" for applying for and securing the research allowance. Only in this way they can continue to expand their projects and achieve key milestones. External consultants or specialised advisory firms play a pivotal role here: they handle every aspect of the application process—whether large or small—and ensure that the state research allowance is approved within an optimal timeframe.Here are the reasons why companies enlist the support of an external consultant—and how the internal and regulatory challenges associated with the application process for claiming the research allowance are overcome.1. Preliminary project assessmentThe consultancy firm will critically analyse the project and evaluate whether it meets the Frascati criteria and qualifies as a research project. This initial step on the one hand serves to plan the subsequent documentation and the application process and on the other hand to maximise the benefits of the research allowance, while simultaneously avoiding unnecessary effort regarding ineligible activities.This step supports the company by:Clarifying any uncertainties regarding eligibility criteria.Ensuring that only eligible projects proceed to the research allowance application stage.Restructuring any project plans identified as problematic.2. Strategic consultationProfessional strategic consulting in the field of research funding goes far beyond the mere submission of applications. It identifies all potential funding opportunities within the company, analyses existing and planned innovation projects, and outlines how these can be optimally leveraged for the research allowance. Based on a sound funding and financial strategy, companies receive practical recommendations that integrate seamlessly with their innovation and growth objectives.The strategic added value lies particularly in the early identification of eligible projects, the maximisation of available funding, and the sustainable optimisation of research and development budgets. At the same time, companies benefit from greater planning certainty, improved liquidity, and more efficient resource allocation.3. Precise and audit-proof project documentationOne of the most common mistakes applicants must avoid when applying for R&D tax credits is inadequate documentation. All information regarding eligible expenses incurred, timesheets, work packages, and other relevant details must be recorded. Most companies conducting R&D activities lack clarity regarding which expenses qualify as eligible, how to distinguish between different cost categories, how to track the working hours of project personnel, and which guidelines must be followed when documenting these processes. This is precisely where the Clusterix software platform provides vital support to applicants by offering all necessary solutions in a single, centralised location, and thereby helping to successfully secure their R&D tax credits.4. Time savingThe process for successfully applying for the research allowance is extensive. External consultants can help a company save time by handling the complex application procedure, allowing the company to focus on its core productive tasks in R&D. Examples of how an external consultant can support the applicant include:Full management of application documentation – from preparing the necessary records to drafting and submitting the application on time.Professional communication with the relevant authorities – including responding to inquiries and guiding the company through the entire approval process.Relieving internal resources – reducing administrative burdens so that specialist and development teams can focus on their R&D projects.Ensuring compliance with funding requirements – minimising potential errors and increasing the chances of success through expert knowledge of funding programs.Efficient process management and time savings – structured coordination of all application steps to accelerate the overall procedure.Strategic identification of additional funding opportunities – uncovering further eligible activities and optimising the utilisation of available funding.5. Error-free submissionThe requirements for successfully applying for the research allowance are complex and demand both technical and regulatory expertise. Experienced consultants assist companies in identifying and avoiding common pitfalls at an early stage.Key aspects include:Ensuring application documents are complete and compliant with funding guidelines to avoid queries, requests for additional information, or delays in the review process.Presenting research and development projects precisely and transparently, in accordance with the requirements of the certification body and tax authorities.Adhering to all legal stipulations, funding criteria, and relevant technical definitions to ensure a compliant application.Early identification of potential weaknesses and compliance risks within the application process.Reducing the risk of rejection or funding reductions through the professional review of all submitted information.Ensuring quality through expert knowledge and best practices gained from numerous successfully supported funding projects.This support increases the likelihood of a successful application and lays the foundation for an efficient and smooth approval of the research allowance.6. Higher success rate The consultancy firm stays constantly up to date with the latest changes to funding laws and regulations and boasts a proven track record from previous projects—factors that provide the applicant with decisive advantages throughout the process. By submitting a meticulously prepared application featuring technically sound descriptions and avoiding procedural errors, the applicant can fully leverage the external consultant's expertise, thereby significantly increasing their approval rate.7. Maximum funding amount An experienced consultancy helps companies unlock the full financial potential of the research allowance. To achieve this, all eligible cost categories are systematically identified, accurately documented, and optimally integrated into the application strategy. This ensures that relevant personnel, contract, and project costs are fully accounted for and the eligible assessment base is maximised.Strategic management of the research allowance is particularly important for corporate groups. Since the statutory assessment base applies across the entire group, the consultancy assists with the centralised recording, monitoring, and allocation of eligible expenses across all affiliated entities. This ensures that available funding opportunities are optimally utilised group-wide and that no claims are lost due to a lack of transparency or insufficient coordination.8. Long-term partnership The research allowance offers companies the opportunity to secure ongoing funding for their innovation projects. A long-term collaboration with a specialised consultancy creates sustainable added value: master data, corporate information, and project documentation already on file can be reused for future applications, significantly reducing administrative effort.At the same time, valuable economies of scale emerge as established processes, existing documentation, and insights gained from previous projects can be leveraged for further funding applications. This shortens processing times, lowers internal workloads, and boosts the efficiency of overall funding management.Furthermore, companies benefit from the continuous assessment of new funding opportunities, strategic funding, financial planning, and ongoing advice regarding legislative changes. This results in more efficient application processes, optimal utilisation of available funding, and greater planning certainty for future R&D projects.9. Cost advantage and one-stop solutionPartnering with a specialised consultancy represents a sound economic investment for many companies. By professionally identifying and fully leveraging available funding opportunities, companies can often achieve financial benefits that significantly exceed the cost of the consulting services themselves.Key added values include:Maximising funding by comprehensively capturing all eligible R&D costs.Reducing the risk of rejection or funding cuts through compliant applications and technically sound project documentation.Relieving the burden on internal resources, allowing specialist departments to focus on value-generating research and development activities.Achieving economies of scale for recurring applications by reusing master data, established processes, and existing documentation.Lowering administrative costs by outsourcing time-consuming application and documentation tasks.Furthermore, specialised consultancies often offer integrated, end-to-end solutions—ranging from funding potential analysis, technical project assessment, and digital documentation to the successful submission of applications. The use of modern software platforms enables efficient data collection, transparent project management, and audit-proof documentation.In particular, the combination of funding expertise, technological know-how, and digital processes creates a sustainable competitive advantage: companies benefit from increased efficiency, reduced internal workload, and optimal utilisation of the research allowance.
Jun 09, 2026
LYNX analyses innoscripta’s scalable software model and profitable growth
LYNX Broker examines innoscripta’s position as a leading provider of digital solutions for research and development management. The analysis focuses on the company’s cloud-based platform, the digitalisation of complex R&D documentation and funding processes, and its strong revenue and earnings growth in recent years. It also assesses innoscripta’s profitability and development since the IPO from a capital markets perspective.Read more: https://www.lynxbroker.de/boerse/boerse-kurse/aktien/innoscripta-aktie/innoscripta-analyse/?a=3355991804#innoscripta-viel-wachstum-fur-wenig-geld
Jun 06, 2026
innoscripta advances in BOTSI® technology stock ranking
boerse.de reports on innoscripta’s recent upgrade in the BOTSI® ranking of the boerse.de Trendinvestor Technology Stocks universe. As part of the latest trend analysis, the company improved its position within the broad technology investment universe. The development reflects increasing capital market recognition of innoscripta and its positive positioning within the technology-focused equity segment.Learn more: https://www.boerse.de/nachrichten-amp/BOTSI-Advisor-Hochstufung-Innoscripta-von-Rang-408-auf/38374935
Jun 03, 2026
Börse Express highlights scalability and international growth plans at innoscripta
Börse Express reports on innoscripta’s strong operational performance and highlights the scalability of the Clusterix platform, which is reflected in significantly improved profitability. The article also discusses the company’s planned expansion into France and capital market expectations regarding its future growth potential.Read more: https://www.boerse-express.com/news/articles/innoscripta-aktie-21250-euro-analystenziel-912913
May 27, 2026
Stock World highlights Clusterix scalability and strong profitability growth
Stock World reports on innoscripta’s strong business performance in the first quarter of 2026. The article emphasizes revenue growth, the EBIT margin of 67.7% and the scalability of the Clusterix SaaS platform as key drivers of profitability. It also highlights the company’s focus on further expanding its core markets in Germany and France while pursuing expansion into additional international markets.Read more: https://www.stock-world.de/innoscripta-aktie-ebit-marge-klettert-auf-677-prozent/?cmplz-force-reload=1780927502360
May 27, 2026
stock3 analyses the scalability and profitability of innoscripta’s business model
stock3 highlights innoscripta’s development and emphasizes the scalability of its software-based business model. The analysis focuses on strong revenue growth in the first quarter of 2026 and increasing profitability, which it views as evidence of the company's operational strength and consistent growth.Read more: https://stock3.com/news/innoscripta-kgv-nur-bei-10-trotz-64-gewinnwachstum-17091919
May 26, 2026
Strong Q1 2026 results highlight innoscripta’s scalable growth strategy
Wallstreet Online reports on innoscripta’s strong business performance in the first quarter of 2026, highlighting profitable growth, the scalability of the company’s business model and the continued development of the Clusterix platform. In addition, disciplined cost management, international expansion, and improved conditions for research and development are identified as important drivers of the company's ongoing development.Read more: https://www.wallstreet-online.de/nachricht/20920485-innoscripta-se-impressive-first-quarter-sets-stage-for-growth
May 25, 2026
Börse Express highlights the end of the lock-up period, Clusterix growth and innoscripta’s expansion into France
Börse Express reports on the expiration of innoscripta’s lock-up period and its potential implications for share liquidity. The article also highlights the company’s operational progress, including a new multi-year agreement for the Clusterix SaaS platform, expansion into France and innoscripta’s growth targets for the 2026 financial year.Read more: https://www.boerse-express.com/news/articles/innoscripta-aktie-lock-up-frist-endet-am-wochenende-909186
